Endocrine therapy for ERα-positive ovaries shares some similarities with ERα-positive breast cancer in that endocrine therapy uses drugs that block estrogen receptors or lower estrogen levels to slow or stop the growth of ERα-positive cancer cells. Here, ESR1 is linked to cancer.